$PLAO
Patria Latin American Opportunity Acquisition Corp.

2024 Q3 Form 10-Q Financial Statement

#000121390024099252 Filed on November 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $194.9K
YoY Change -18.8%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $194.9K
YoY Change -18.8%
Operating Profit -$194.9K
YoY Change -19.16%
Interest Expense $12.25K
YoY Change -99.39%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income $814.0K
YoY Change -54.01%
Income Tax
% Of Pretax Income
Net Earnings $814.0K
YoY Change -53.91%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.08
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $53.24M
YoY Change -71.08%
Cash & Equivalents $8.670K
Short-Term Investments $53.23M
Other Short-Term Assets $149.1K
YoY Change 49.13%
Inventory
Prepaid Expenses $149.1K
Receivables
Other Receivables
Total Short-Term Assets $53.39M
YoY Change -71.03%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $53.39M
Total Long-Term Assets $0.00
Total Assets $53.39M
YoY Change -71.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.003K
YoY Change -96.9%
Accrued Expenses $68.95K
YoY Change -7.77%
Deferred Revenue
YoY Change
Short-Term Debt $4.866M
YoY Change 305.46%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $10.08M
YoY Change -9.24%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.08M
Total Long-Term Liabilities $0.00
Total Liabilities $10.08M
YoY Change -9.24%
SHAREHOLDERS EQUITY
Retained Earnings -$10.02M
YoY Change -7.21%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$9.927M
YoY Change
Total Liabilities & Shareholders Equity $53.39M
YoY Change -71.03%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $814.0K
YoY Change -53.91%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$500.0K
YoY Change 257.15%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$204.4K
YoY Change -77.29%
Cash From Investing Activities -$204.4K
YoY Change -77.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 689.4K
YoY Change -23.4%
NET CHANGE
Cash From Operating Activities -500.0K
Cash From Investing Activities -204.4K
Cash From Financing Activities 689.4K
Net Change In Cash -15.01K
YoY Change -89.28%
FREE CASH FLOW
Cash From Operating Activities -$500.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Entity Address Country
EntityAddressCountry
KY
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
usd
plao Deemed Contribution For Administrative Support Related Party
DeemedContributionForAdministrativeSupportRelatedParty
usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41321
dei Entity Registrant Name
EntityRegistrantName
PATRIA LATIN AMERICAN OPPORTUNITY ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Address Address Line1
EntityAddressAddressLine1
60 Nexus Way
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Camana Bay
dei Entity Address Address Line3
EntityAddressAddressLine3
PO Box 757, Grand
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-9006
dei City Area Code
CityAreaCode
+1 345
dei Local Phone Number
LocalPhoneNumber
640 4900
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8670 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47046 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
149126 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
50967 usd
CY2024Q3 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
53231709 usd
CY2023Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
187355645 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
53389505 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
187453658 usd
CY2024Q3 us-gaap Assets
Assets
53389505 usd
CY2023Q4 us-gaap Assets
Assets
187453658 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7003 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
241365 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
68948 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
74757 usd
CY2024Q3 plao Deferred Underwriting Fees Payable Current
DeferredUnderwritingFeesPayableCurrent
4025000 usd
CY2023Q4 plao Deferred Underwriting Fees Payable Current
DeferredUnderwritingFeesPayableCurrent
4025000 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1118000 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
780000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10084482 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7221122 usd
CY2024Q3 us-gaap Liabilities
Liabilities
10084482 usd
CY2023Q4 us-gaap Liabilities
Liabilities
7221122 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
53231709 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
187355645 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
90000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10017261 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7123684 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-9926686 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-7123109 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53389505 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187453658 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
194881 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
241063 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
765046 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
928551 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-194881 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-241063 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-765046 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-928551 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-306800 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
353600 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
338000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-780000 usd
CY2024Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
714328 usd
CY2023Q3 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
2360877 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
5404525 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
7601882 usd
CY2024Q3 us-gaap Interest Expense
InterestExpense
12252 usd
us-gaap Interest Expense
InterestExpense
18047 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
813995 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1766214 usd
us-gaap Net Income Loss
NetIncomeLoss
4283432 usd
us-gaap Net Income Loss
NetIncomeLoss
7453331 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-7123109 usd
CY2024Q1 plao Adjustments To Additional Paid In C Deemed Contribution For Administrative Support Related Party
AdjustmentsToAdditionalPaidInCDeemedContributionForAdministrativeSupportRelatedParty
30000 usd
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3336139 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1420470 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-9008778 usd
CY2024Q2 plao Adjustments To Additional Paid In C Deemed Contribution For Administrative Support Related Party
AdjustmentsToAdditionalPaidInCDeemedContributionForAdministrativeSupportRelatedParty
30000 usd
CY2024Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2922179 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
2048967 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-9851990 usd
CY2024Q3 plao Adjustments To Additional Paid In C Deemed Contribution For Administrative Support Related Party
AdjustmentsToAdditionalPaidInCDeemedContributionForAdministrativeSupportRelatedParty
30000 usd
CY2024Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
918691 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
813995 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-9926686 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-9446266 usd
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2569175 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2278938 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-9736503 usd
CY2023Q2 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
2971830 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
3408179 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-9300154 usd
CY2023Q3 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
3260877 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
1766214 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-10794817 usd
us-gaap Net Income Loss
NetIncomeLoss
4283432 usd
us-gaap Net Income Loss
NetIncomeLoss
7453331 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
5404525 usd
us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
7601882 usd
us-gaap Interest Expense
InterestExpense
18047 usd
plao Deemed Contribution For Administrative Support Related Party
DeemedContributionForAdministrativeSupportRelatedParty
90000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
338000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-780000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
98159 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-173901 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-234362 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
226158 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-5809 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
6130 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1013376 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-522362 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
438723197 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
672783585 usd
plao Proceeds From Redemption Of Us Government Treasury Obligations
ProceedsFromRedemptionOfUSGovernmentTreasuryObligations
436950712 usd
plao Proceeds From Redemption Of Us Government Treasury Obligations
ProceedsFromRedemptionOfUSGovernmentTreasuryObligations
671583585 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
141300945 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
65163747 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
139528460 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
63963747 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
141300945 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
65163747 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
2747485 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1200000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-3144 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-138553460 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63966891 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-38376 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-525506 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47046 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
707749 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8670 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
182243 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
7177010 usd
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
8801882 usd
CY2024Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1000000 usd
us-gaap Underwriting Income Loss
UnderwritingIncomeLoss
13779665 usd
us-gaap Other Underwriting Expense
OtherUnderwritingExpense
8050000 usd
us-gaap Payments For Underwriting Expense
PaymentsForUnderwritingExpense
4600000 usd
plao Other Offering Costs
OtherOfferingCosts
1129665 usd
us-gaap Other General Expense
OtherGeneralExpense
314508 usd
us-gaap Temporary Equity Other Changes
TemporaryEquityOtherChanges
13456157 usd
CY2022Q1 plao Investment Maximum Maturity Term
InvestmentMaximumMaturityTerm
P185Y
CY2024Q3 plao Percentage Of Public Shares
PercentageOfPublicShares
1 pure
CY2024Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
16880481 shares
CY2024Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
12339057 shares
CY2024Q2 us-gaap Deposits
Deposits
272484 usd
CY2024Q3 us-gaap Deposits
Deposits
136042 usd
CY2024Q3 plao Percentage Of Net Assets Held In Trust Account
PercentageOfNetAssetsHeldInTrustAccount
0.80 pure
plao Investment Maximum Maturity Term
InvestmentMaximumMaturityTerm
P185D
CY2024Q3 plao Public Shares Redeemed Percentage
PublicSharesRedeemedPercentage
1 pure
us-gaap Interest Expense Other
InterestExpenseOther
100000 usd
CY2024Q3 plao Trust Account Shares Price
TrustAccountSharesPrice
10.3
CY2024Q3 plao Working Capital Amount
WorkingCapitalAmount
43305023 usd
CY2024Q3 plao Working Capital Deficit
WorkingCapitalDeficit
-4783686 usd
CY2024Q3 us-gaap Cash
Cash
8670 usd
CY2024Q3 us-gaap Substantial Doubt About Going Concern Within One Year
SubstantialDoubtAboutGoingConcernWithinOneYear
true
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of these unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
8670 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
47046 usd
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
7177010 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
us-gaap Sale Of Stock Description Of Transaction
SaleOfStockDescriptionOfTransaction
Each Unit consists of one share of Class A Ordinary Share and one-half of one redeemable warrant (“Public Warrant”).
CY2024Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
12339057 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
90000 shares
CY2022Q1 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
662245 usd
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.36
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
662245 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
662245 usd
CY2024Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
30000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
90000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
30000 usd
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
60000 usd
CY2024Q3 plao Workings Capital Loans
WorkingsCapitalLoans
2000000 usd
plao Underwriters Option Period
UnderwritersOptionPeriod
P45D
plao Underwriting Discount Per Unit
UnderwritingDiscountPerUnit
0.2
plao Deferred Underwriting Commission Per Unit
DeferredUnderwritingCommissionPerUnit
0.35
CY2023Q4 plao Percentage Of Deferred Underwriting Fees Payable
PercentageOfDeferredUnderwritingFeesPayable
0.50 pure
plao Warrants Exercisable Period
WarrantsExercisablePeriod
P30D
plao Later Than Business Days After The Closing Initial Business Combination
LaterThanBusinessDaysAfterTheClosingInitialBusinessCombination
P20D
plao Effective Business Days
EffectiveBusinessDays
P60D
CY2024Q3 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
plao Gross Proceeds Rate
GrossProceedsRate
0.60 pure
plao Redemption Trigger Price Per Share
RedemptionTriggerPricePerShare
18
plao Market Value Percentage
MarketValuePercentage
1 pure
plao Newly Issued Price Percentage
NewlyIssuedPricePercentage
1.80 pure
plao Completion Of The Initial Business Combination Days
CompletionOfTheInitialBusinessCombinationDays
P30D
plao Trading Days Endingonthe Third Trading Day Prior Days
TradingDaysEndingontheThirdTradingDayPriorDays
P30D
plao Redemptionof Warrants Price
RedemptionofWarrantsPrice
18
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
780000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
338000 usd
CY2024Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1118000 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2340000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-780000 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1560000 usd
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
us-gaap Interest Expense
InterestExpense
usd
CY2024Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
us-gaap Interest Expense
InterestExpense
usd
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001849737

Files In Submission

Name View Source Status
0001213900-24-099252-index-headers.html Edgar Link pending
0001213900-24-099252-index.html Edgar Link pending
0001213900-24-099252.txt Edgar Link pending
0001213900-24-099252-xbrl.zip Edgar Link pending
ea0220407-10q_patria.htm Edgar Link pending
ea022040701ex31-1_patria.htm Edgar Link pending
ea022040701ex31-2_patria.htm Edgar Link pending
ea022040701ex32-1_patria.htm Edgar Link pending
ea022040701ex32-2_patria.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
plao-20240930.xsd Edgar Link pending
plao-20240930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
plao-20240930_def.xml Edgar Link unprocessable
plao-20240930_pre.xml Edgar Link unprocessable
plao-20240930_lab.xml Edgar Link unprocessable
ea0220407-10q_patria_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending